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From the Medical Research Council Centre for Inflammation
Research,* University of Edinburgh, Edinburgh, United Kingdom;
the La Jolla Institute for Allergy and Immunology,† University of
California, San Diego, California; and the Department of
Medicine,‡ University of Cape Town, Cape Town, South Africa
Activated macrophages (M) isolated from inflamed
glomeruli or generated by interferon- and lipopoly-
saccharide treatment in vitro induce glomerular mes-
angial cell apoptosis by hitherto incompletely under-
stood mechanisms. In this report we demonstrate
that nitric oxide-independent killing of co-cultured
mesangial cells by interferon-/lipopolysaccharide-
activated M is suppressed by binding/ingestion of
apoptotic cells and is mediated by tumor necrosis
factor (TNF). Thus, soluble TNF receptor-1 signifi-
cantly inhibited induction of mesangial cell apoptosis
by 1) rodent M in the presence of nitric oxide syn-
thase inhibitors or 2) human M , both situations in
which nitric oxide release was minimal. Further-
more, murine TNF knockout M were completely
unable to induce mesangial cell apoptosis in the pres-
ence of nitric oxide synthase inhibitors. We conclude
that TNF-restricted M-directed apoptosis of glomer-
ular mesangial cells can be down-regulated by M
binding/ingestion of apoptotic cells, suggesting a new
mechanism for negative feedback regulation of M
controls on resident cell number at inflamed sites.
(Am J Pathol 2001, 159:1397–1404)
Proliferation of resident cells is a prominent feature of
inflammatory responses. In glomerular inflammation there
is typically an increase in number of resident glomerular
mesangial cells that adopt a myofibroblast-like pheno-
type, lay down excess abnormal matrix, and thereby
threaten progression to scarring.1 However, in self-lim-
ited nephritis excess mesangial cells are deleted by ap-
optosis and the glomerular cell complement returns to
normal.2,3 Until recently the mechanisms mediating de-
letion of myofibroblast-like mesangial cells have been
obscure. However, we showed that activated macro-
phages (M) can direct apoptosis of such cells,4 mes-
angial cell killing being mediated by nitric oxide (in a
rodent cell system) and another unknown factor. Be-
cause inflammatory M can delete neutrophils5 and a
range of tumor cells6–8 by tumor necrosis factor (TNF)-
mediated mechanisms, there was a strong possibility that
activated M might use TNF to induce mesangial cell
apoptosis, particularly in human cell systems in which M
production of nitric oxide is notoriously difficult to detect.9
Furthermore, the demonstration that activated/inflam-
matory M can kill resident glomerular cells immediately
begs the question as to how the killing capacity of M
might be regulated. Importantly, work from Reiter and
colleagues10 demonstrated that the capacity of rodent
bone marrow-derived M stimulated with interferon
(IFN)- and lipopolysaccharide (LPS) to induce tumor cell
apoptosis was diminished to 30% of control by inges-
tion of apoptotic cells. However, although this was asso-
ciated with a modest reduction in nitric oxide production
to 75% of control, the M killing mechanism(s) sup-
pressed by ingestion of apoptotic cells was/were not
characterized further.10
In this study we set out to determine whether activated
M induction of glomerular mesangial cell apoptosis was
suppressed by M ingestion of apoptotic cells and to
determine which M mechanisms for triggering apopto-
sis in neighboring mesangial cells were subject to such
control.
Materials and Methods
Materials
Media and fetal calf serum (FCS) were purchased from
Life Technologies (Paisley, UK). Tissue culture plastic
was from Falcon (Becton Dickinson, Mountainview, CA)
and Costar (Cambridge, MA) as stated in the text. Cyto-
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kines were purchased from R&D Systems (Minneapolis,
MN) and all other reagents from Sigma (St. Louis, MO)
unless otherwise stated.
Cell Isolation and Preparation
Human mesangial cells were obtained from the cortex of
fresh nephrectomy specimens. Mesangial cells were pu-
rified from outgrowths of whole, purified glomeruli and
passaged according to standard techniques in full Dul-
becco’s modified Eagle’s medium (DMEM)/F12 (with
10% FCS, and supplemented with penicillin and strepto-
mycin (Life Technologies).2 Rat mesangial cells were
derived from outgrowths of whole glomeruli as de-
scribed.4 They were passaged according to standard
techniques in full DMEM/F12, and were used between
passage 6 and 14. Rodent macrophages were derived
from bone marrow taken from the femur of Wistar rats or
from murine strains (TNF//) and wild-type littermate
controls (C57BL6  129sv). In the TNFR1-Fc blockade
studies, they were all C57BL6). Marrow was prepared
and cultured in Teflon bags with murine M-CSF as previ-
ously described.4 Cells were used after 7 to 10 days, then
were plated into wells 16 hours before experimentation to
ensure adequate adhesion and correct cell number. Hu-
man macrophages were derived from peripheral blood
monocytes. Briefly, peripheral blood mononuclear cells
were obtained from the buffy coat of fresh peripheral
blood from healthy donors. Red cells were removed by
dextran sedimentation and granulocytes were separated
by centrifugation through a discontinuous Percoll gradi-
ent.11 The monocytes were then purified using the MACS
monocyte cell isolation system (Miltenyi Biotech, Co-
logne, Germany). Purity of monocytes (95%) was es-
tablished by flow cytometric characteristics. Monocytes
were then cultured in Teflon wells (2  106/ml) in
Iscove’s-modified DMEM with 10% autologous serum.
Medium was changed on day 2 and day 4. Differentiation
was confirmed by cytology on cytospins and CD14 im-
munofluorescence (not shown).
Generation of Apoptotic Cells
Rat mesangial cells were induced into apoptosis by ul-
traviolet irradiation. Subconfluent monolayers in T75
flasks (Costar) were exposed to UV irradiation (312 nm, 8
W, 3 minutes) followed by incubation for 16 hours. Non-
adherent (apoptotic) cells were removed by agitation and
collected in the supernatant. After centrifugation, apopto-
tic cells were further purified by washing with phosphate-
buffered saline (PBS) 1 and centrifugation (190  g, 5
minutes). Apoptosis was confirmed by histology, selec-
tive uptake of Hoechst 33342 (1 g/ml), but exclusion of
propidium iodide (PI) (1 g/ml). Typically, 10% of cells
were PI-positive and 5% did not exclude trypan blue
(0.2%).
Mouse thymocytes were prepared from 20 g C57/BL6
mice by pressing the thymus through a 50-m sieve. The
single cell supernatant was resuspended (2  106 cells/
ml) in RPMI supplemented with glutamine and 2-mercap-
toethanol in addition to 10% FCS and antibiotics. Cells
were either exposed to a 5-minute burst of UV irradiation
(312 nm, 8 W) followed by 2.5 hours of culture, or dexa-
methasone (1 mol/L) followed by culture for 6 hours.
Typically50% of induced cells were apoptotic (Annexin
V binding; Boehringer Mannheim. Mannheim, Germany)
and permeable to Hoescht 33342 (1 g/ml)) whereas
5% of those were positive for the uptake of PI (flow
cytometric analysis, data not shown).
Co-Culture of M and Mesangial Cells
For a detailed description, see our earlier work.4 Matured
rodent bone marrow-derived macrophages were plated
in 96-well plates initially at a density to cover 60 to 70% of
the well surface; typically this required 2  104cells per
well. Rat mesangial cells were prelabeled with Cell-
Tracker Green 5-chloromethylfluorescein diacetate
CMFDA (Molecular Probes, Eugene, OR): cell cultures,
70 to 80% confluent, were washed with medium lacking
serum and then incubated for 1 hour in serum-free me-
dium containing CMFDA at 5 ng/ml. Cells were washed in
medium containing 10% FCS to remove any unbound
CMFDA, then trypsinized and added to cultured rodent
M in a 1.5 M:1.0 mesangial cell ratio, previously shown
to be optimal for demonstration of macrophage-directed
mesangial cell apoptosis.4 Experiments were performed
in DMEM/F12 medium containing 10% FCS. Once cells
had become adherent, typically 2 to 4 hours, wells were
washed to remove nonadherent cells. In our earlier
work4mixing unlabeled and labeled cells showed no ev-
idence of transfer of CMFDA from labeled to unlabeled
cells. Rodent co-cultures were activated with IFN- (100
U/ml) plus LPS (1 g/ml).
In some experiments, unlabeled apoptotic cells (1 
105 per well of a 96-well plate) were added to the estab-
lished co-culture and to the control wells of mesangial
cells alone, at the same time as activating cytokines. As
a control for apoptotic cells, aliquots of 10-m diameter
sterile latex beads (Polysciences, UK) were added to
adjacent co-culture. When thymocytes were used as ap-
optotic cells, aliquots were added to co-culture for 6
hours, then noningested cells gently washed away, be-
fore activation. In separate wells containing M alone,
apoptotic cells or latex beads were also incubated for 6
hours, then washed off, and wells were fixed for quanti-
fication of percentage M that had phagocytosed apo-
ptotic cells. This was assessed by phase contrast micros-
copy. M (34  5.6%) phagocytosed at least one
apoptotic thymocyte and 30  6.7% phagocytosed ap-
optotic mesangial cells. M (67  8.4%) ingested latex
beads. By contrast only 1  1% of M phagocytosed the
population of live thymocytes in this assay.
For human co-culture, human monocyte-derived M
were plated at 2  104 per well as above. Cycling human
mesangial cells were primed with IFN- (500 U/ml) for 24
hours, then prelabeled with CMFDA as described for rat
mesangial cells. Once washed and trypsinized, they
were added to wells in a 2:1 ratio (because of the larger
size of human mesangial cells). After 4 hours, wells were
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washed and replaced with full DMEM/F12. Human co-
cultures were activated with human IFN- (Peprotech)
(500 U/ml) and LPS (1 g/ml).
Assessment of Mesangial Cell Apoptosis in Co-
Culture
For a detailed description, see our earlier work.4 At the
end of co-culture experiments, wells were either fixed
with formaldehyde (4% final concentration) and stored for
48 hours at 4°C to allow firm adhesion of apoptotic cells
to the plate, or they were assessed live by fluorescence
microscopy after the addition of Hoechst 33342 (1 g/ml)
and PI (1 g/ml). For assessment of live cells, green
rounded-up cells were scored as apoptotic if they also
were positive for Hoechst uptake, but excluded PI. For
assessment of fixed (and permeabilized) cells by mor-
phology, plates were first counterstained with PI (1 g/ml)
and Hoechst (1 g/ml) in PBS for 5 minutes (which stains
both M and mesangial cells). After discarding the stain,
wells were covered with a fluorescent mountant. Apopto-
tic mesangial cells were easily discernible by green flu-
orescence and characteristic morphology. For both live
and fixed wells, apoptosis of mesangial cells was as-
sessed blindly and five fields per well were randomly
chosen without observer bias. Each experiment was per-
formed in triplicate. Previous studies have shown this
method to give similar results to flow cytometric assays.4
However, the microscopical assay is reproducibly more
sensitive because apoptotic mesangial cells tend to dis-
integrate during centrifugation once they have been
fixed. Note that when exogenous apoptotic cells were
added these were not labeled with fluorescent dyes,
enabling confident identification of apoptosis in the pre-
viously healthy target mesangial cells.
Assays of TNF- and Nitric Oxide
Culture supernatants (free from phenol red) were har-
vested, clarified by centrifugation (4000  g, 5 minutes)
then stored at 20°C. After complete thawing, 50 l of
each sample was assayed by Quantikine mouse TNF-
enzyme-linked immunosorbent assay (R&D Systems) ac-
cording to the manufacturer’s instructions. A standard
curve with absorbencies from 0.1 to 1.2 was achieved on
each occasion. Samples (50 l) were assayed for nitrite
by mixing with an equal volume of the Griess reagent as
previously described6 and measuring absorbency at 540
nm and comparing with a sodium nitrite standard curve.
Chimeric Soluble Death Receptors
Fusion proteins were constructed using cDNAs for the
extracellular domains of human receptors fused with the
Fc portion of human IgG1. Proteins were expressed in
insect cells infected with recombinant baculoviruses.
Protein secreted into the culture supernatant was then
purified by protein A-Sepharose column affinity. The pro-
tein was stored at 20°C in Hanks’ salt solution.12
Knockout Mice
TNF-/TNF- double-knockout mice were generated by
inserting a targeting vector between exon 1 and 2 of the
murine TNF- gene and the middle of exon 4 of the
adjacent murine TNF- gene of chromosome 17 of GS1
mouse embryonic stem cells. Mutant embryonic stem
cells were selected and injected into C57/BL6 blasto-
cysts.13
Statistics
All experiments were performed on at least four separate
occasions using at least four animals. The data were
expressed as mean values with the SE of mean. Paired
data were compared using the t-test and multiple com-
parisons using analysis of variance.
Results
Ingestion of Apoptotic Cells by Activated
Rodent M Selectively Suppresses Nitric Oxide-
Independent Induction of Mesangial Cell
Apoptosis
In our previous studies of IFN-/LPS-activated rodent
bone marrow-derived M killing of rodent mesangial cells
primed with IFN- (Figure 1) we demonstrated that at
least half of the mesangial cell killing was independent of
M-derived nitric oxide, being unaffected by inhibitors of
inducible nitric oxide synthase (iNOS) such as L-NMMA
at 500 mol/L.4 We also observed that the vast majority of
mesangial cells induced into apoptosis by activated M
were not ingested,4 presumably because of kinetic and
spatial restraints in a two-dimensional culture system in
which IFN--primed mesangial cells were added above a
sparse monolayer of M before the co-culture was acti-
vated by addition of IFN- and LPS.
Therefore, to test whether ingestion of apoptotic cells
diminished M capacity to trigger apoptosis in mesangial
cells, an established co-culture of IFN--primed rat mes-
angial cells with rat M was exposed to a fivefold excess
of mesangial cells induced into apoptosis by UV irradia-
tion; the apoptotic cells were administered at the same
time as activation of the co-culture with IFN- and LPS.
Under standard conditions, there was no significant ef-
fect of apoptotic cells on M induction of mesangial cell
apoptosis. However, in the presence of 200 mol/L L-
NMMA, apoptotic mesangial cells exerted a dramatic
inhibitory effect on M induction of mesangial cell apo-
ptosis (Figure 2). Addition of the same number (1  105
per well) of 10-m latex beads, as a control phagocytic
particle, had no inhibitory effect whether L-NMMA was
present or not (Figure 3). Furthermore, suppression of
nitric oxide-independent triggering of apoptosis was ob-
served with rodent thymocytes induced into apoptosis by
UV or dexamethasone, but not when freshly isolated no-
napoptotic thymocytes were used as controls (Table 1).
Finally, similar results were observed whether apoptotic
Phagocytosis of Apoptotic Cells Inhibits Macrophage Killing 1399
AJP October 2001, Vol. 159, No. 4
Figure 1. Fluorescent micrograph (original magnification, 320) showing activated co-culture of CMFDA green-labeled mesangial cells with M. The co-culture
was established according to Materials and Methods and activated with IFN- (100 U/ml) plus LPS (1 g/ml) after 4 hours of exposure to preformed unlabeled
apoptotic mesangial cells. At 24 hours, the co-culture was fixed and later counterstained with PI (1 g/ml). Apoptotic green mesangial cells are clearly seen with
red/orange pyknotic nuclear material and are readily distinguished from M (arrows). Before fixation, co-culture was exposed to Hoechst 33342 (1 g/ml) for
confirmation of apoptosis of the green mesangial cells (see inset). Note inset field and arrow-marked apoptotic cells correspond to central field of main figure.
Note also two apoptotic mesangial cells showing cytoplasmic blebbing (large arrows).
Figure 2. Induction of rodent mesangial cell apoptosis by activated M is
blocked by simultaneous phagocytosis of apoptotic mesangial cells when
iNOS inhibitors are present. Established co-cultures of rodent M and IFN-
primed, CMFDA-labeled, mesangial cells, or mesangial cells growing alone
(as control), were activated with IFN- (100 U/ml) and LPS (1 g/ml).
Simultaneously to activation, a fivefold excess of unlabeled apoptotic rodent
mesangial cells was added (1 105 cells per well). In addition, to some wells
(hatched bars), L-NMMA (200 mol/L) was added at the same time as activa-
tion. After 24 hours of incubation, induction of CMFDA-labeled mesangial
cells was scored in all wells. ***, P  0.001 versus no ingestion (n  5).
Figure 3. Induction of rodent mesangial cell apoptosis by activated M is not
blocked by simultaneous phagocytosis of latex beads when iNOS inhibitors
are present. Both established co-cultures of rodent M- and IFN--primed,
CMFDA-labeled, mesangial cells, and wells of mesangial cells alone were
activated with IFN- (100 U/ml) and LPS (1 g/ml). Simultaneously a fivefold
excess of unlabeled sterile 10-m latex beads was added (1  105 cells per
well). In addition, to some wells (hatched bars), L-NMMA (200 mol/L)
was added. After 24 hours of incubation, induction of CMFDA-labeled mes-
angial cells was scored (n  5).
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cells were added simultaneously with activation of co-
culture, as above, or if apoptotic cells were administered
to co-culture before activation (Table 1). This indicates
that the suppressive effect was mediated by effects of
apoptotic cells on the M most likely consequent on
ingestion of apoptotic cells, but not excluding an effect of
binding alone.
Blockade of TNFR1 Also Inhibits Nitric Oxide-
Independent Macrophage Induction of
Mesangial Cell Apoptosis
Exposure of activated monocytes/macrophages to apo-
ptotic cells exerts a well-established inhibitory effect on
secretion of TNF.14,15 It therefore seemed especially
likely that nitric oxide-independent induction of IFN--
primed mesangial cell apoptosis by activated M, which
we had found to be inhibited by apoptotic cells (Figure 2),
was also mediated by M-derived TNF.
To seek a role for TNF in M directed killing of mes-
angial cells, we examined the effect of soluble chimeric
death receptors (fused with the Fc portion of human
IgG1) on activated rat macrophage killing of primed rat
mesangial cells in the presence of inhibitors of nitric
oxide synthesis (in these experiments the selective iNOS
inhibitor L-NIL at 30 mol/L, as validated in our earlier
work4). A role for M-derived FasL had already been
ruled out in rodent co-culture4 by using bone marrow M
from gld/gld mice (that lack active FasL) and therefore
soluble inhibitors of Fas-FasL interaction were not used.
Induction of rat mesangial cell apoptosis in activated
co-culture was assessed at 24 hours. TNFR1-Fc (10 g/
ml) was able to reduce significantly the killing capacity of
M in co-culture (Figure 4) whereas lymphotoxin -re-
ceptor fusion protein (LTR-Fc16) and herpesvirus entry
mediator fusion protein (HVEM-Fc17,18) had no effect. At
higher concentrations, TNFR1-Fc (50 g/ml) was able to
increase further the reduction in killing capacity (14.3 
3.3% rat mesangial cell apoptosis in activated co-culture
with IgG1 versus 3.9  0.7% mesangial cell apoptosis
with 50 g/ml TNFR1-Fc), but the reduction was not
complete. Control rat mesangial cells growing alone with
50 g/ml TNFR1-Fc showed 1.3  0.7% apoptosis at 24
hours. The IC50 for this fusion protein was 5.0 1.2 g/ml
(Figure 5).
We were also interested in determining whether TNFR1
blockade might similarly inhibit activated human M in-
duction of mesangial cell apoptosis, because human M
production of nitric oxide is notoriously difficult to elicit.9
Indeed, we confirmed that the IFN-/LPS activation reg-
imen had no significant stimulatory effect on human
monocyte-derived M production of nitric oxide (data not
shown) and that L-NMMA had no effect on activated
human M killing of IFN--primed human mesangial cells
(14.7  2.1% apoptosis at 24 hours with 200 mol/L
L-NMMA versus 15.7 1.9% under control conditions). In
this physiologically nitric oxide-independent human cell
system, soluble TNFR1 again demonstrated selective in-
Table 1. The Effect of Co-Culture with Apoptotic Cells upon
Murine M Induction of Apoptosis in IFN- Primed
Mesangial Cells at 24 Hours in the Presence of
Nitric Oxide Synthesis Inhibitor
Cell type
% Mesangial cell
apoptosis
No added
cells
Cells
added
Apoptotic mesangial cells (UV) 10.7  2.1 3.3  1.0*
Apoptotic thymocytes (UV) 16.1  1.4 8.2  0.1†
Apoptotic thymocytes (Dex) 16.1  1.4 8.3  0.5†
Nonapoptotic thymocytes 16.1  1.8 14.2  1.3
UV, Ultraviolet; Dex, dexamethasone.
Rodent co-culture was established as described in Materials and
Methods. Apoptotic cells were incubated with the co-culture for 6
hours. M were activated with IFN- plus LPS in the presence of L-
NMMA 200 mol/L after washing away noningested cells. Note that
control cultures of mesangial cells alone exposed to apoptotic cells
followed by activating cytokines underwent no greater than 3.42 
0.2% apoptosis.
*P  0.01 compared with no added cells.
†P  0.001 compared with no added cells.
Figure 4. Soluble TNFR1 inhibits nitric oxide-independent rodent M killing
of primed rodent mesangial cells. Murine bone marrow-derived M were
co-cultured with mesangial cells as described in Materials and Methods.
Experiments were activated with IFN- and LPS as described, with L-NIL (30
mol/L) to block NOS 2-mediated killing, and soluble Fc-fusion proteins
TNFR1-Fc, LTR-Fc, HVEM-Fc, or isotype control IgG1 were added in culture
medium at 10 g/ml. Control wells containing mesangial cells but no M
received all reagents. Mesangial cell apoptosis was assessed at 24 hours. Note
a reduction in the capacity of M to induce apoptosis in the presence of
TNFR1-Fc. *, P  0.05.
Figure 5. Concentration-dependent inhibition by sTNFR1 of nitric oxide
independent rodent M induction of rodent mesangial cell apoptosis. Using
the same co-culture assay of mesangial cell apoptosis, a range of concentra-
tions of TNFR1-Fc was added to wells and apoptosis quantified, compared
with 50 g/ml of IgG1 control shown as 0 g/ml of TNFR1-Fc on the curve.
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hibition of activated M direction of mesangial cell apo-
ptosis (Figure 6).
Nitric Oxide-Independent Induction of Mesangial
Cell Apoptosis Is Restricted by Macrophage
TNF
Although the foregoing studies provided strong evi-
dence that ligation of TNFR1 played a major role in
nitric oxide-independent M killing of mesangial cells,
the data did not provide direct evidence that M-
derived ligands for TNFR1 (TNF- and TNF-) were
involved. Furthermore, the failure of sTNFR1 to exert
complete inhibition of killing might have reflected its
physical exclusion from regions of close contact be-
tween macrophages and mesangial cells. To examine
this question definitively, we prepared bone marrow-
derived (BMD) M from double-knockout Tnf/,
Tnf/ mice, and wild-type littermate controls; all
animals used were C57/BL6  129sv to ensure that
strain differences did not complicate interpretation.13
Preliminary studies showed both knockout and wild-
type M produced similar amounts of nitric oxide in
response to IFN- with LPS (50  4.6 [wild type] versus
47.0  3.3 [Tnf//] nmol nitrite per 106 cells per 24
hours) and that this was almost completely inhibited by
the iNOS inhibitor L-NIL at 30 mol/L (to 3.7  2.1 and
2.9  1.9 nmol nitrite per 106 cells per 24 hours,
respectively). Supernatants from M activated with
IFN- and LPS confirmed that the Tnf// M were
completely unable to produce TNF-, as assessed by
enzyme-linked immunosorbent assay of culture super-
natants at 24 hours (wild-type M 3982 pg/ml Tnf/
/ M 0.00 pg/ml). Rat mesangial cells were
primed for 24 hours with IFN- then co-cultured with
either wild-type M or Tnf// M. The co-cultures
were activated with IFN- (100 U/ml) and LPS (1 g/ml)
in the presence of L-NIL (30 mol/L). In these experi-
ments knockout M were completely unable to induce
mesangial cell apoptosis compared with controls of
mesangial cells growing alone in the presence of cy-
tokines (Figure 7). Wild-type M induced mesangial
cell apoptosis as expected. These data demonstrate
that when nitric oxide synthesis was inhibited, and
therefore used as a model of human M-directed ap-
optosis, M production of TNF-/ accounted for all of
the killing effect of rodent M on mesangial cells.
Discussion
Although it has been well documented that M can kill
tumor cells,6–8 it has only very recently become apparent
that macrophages can also direct tissue remodeling by
inducing physiological cell death, in nontransformed res-
ident cells.4,19,20 Thus we have shown previously that
activated M, whether isolated directly from experimen-
tally inflamed glomeruli or generated by IFN-/LPS acti-
vation in vitro can induce apoptosis in cultured primary
mesangial cells.4 In this report, we demonstrate for the
first time that activated M induction of apoptosis in
nontransformed cells can be profoundly inhibited by in-
teraction of M with apoptotic cells. However, in a rodent
system this effect could only be demonstrated when nitric
oxide production was inhibited. Nevertheless, such nitric
oxide-independent direction of mesangial cell apoptosis
was inhibitable by soluble TNF receptor in both a rodent
cell culture system and a physiologically nitric oxide-
independent human cell culture system. Indeed, a major
role for TNF in the rodent system was confirmed by the
failure of knockout M to induce nitric oxide-independent
mesangial cell apoptosis. Therefore, our key conclusion
is that macrophage-derived TNF may play a major role in
directing apoptosis of primary, nontransformed glomeru-
lar mesangial cells.
We also regard it as interesting and important that
TNF-restricted M direction of mesangial cell apoptosis
Figure 6. Induction of apoptosis of human mesangial cells by human mono-
cyte-derived M is mediated by TNFR1 ligation. Co-culture was established
using primed human mesangial cells and M. On activation with IFN- plus
LPS, soluble Fc-fusion proteins TNFR1-Fc, LTR-Fc, HVEM-Fc, or isotype
control IgG1 (10 g/ml) were added in culture medium at 10 g/ml. Also, the
blocking anti-Fas ligand antibody (1 g/ml) was applied to adjacent wells.
Control wells containing human mesangial cells but no M received all
reagents. Note a reduction in the capacity of M to induce apoptosis in the
presence of TNFR1-Fc, but not in the presence of any of the other reagents.
*, P  0.05.
Figure 7. The comparative effect of activated wild-type and Tnf/Tnf/
knockout murine M on apoptosis of mesangial cells primed with IFN-.
Mesangial cells were primed as described for 24 hours in the presence of
IFN- (300 U/ml). Co-culture was established using bone marrow-derived
M from either Tnf/Tnf/ knockout mice or wild-type littermate con-
trols and activated with IFN- (100 U/ml) plus LPS (1 g/ml) in the presence
of L-NIL (30 mol/L) to block NOS 2-mediated killing. Experiments were
assayed after 24 hours. Although the wild-type M were able to induce
mesangial cell apoptosis, the knockout animals incapable of inducing apo-
ptosis greater than that seen in control wells. **, P  0.01 compared with
wild-type co-culture (n  5).
1402 Duffield et al
AJP October 2001, Vol. 159, No. 4
was selectively suppressed by interaction of M with
apoptotic cells but not when healthy cells or latex beads
were used as control particles. These data are in keeping
with the marked suppressive effects of apoptotic cells on
activated rodent bone marrow-derived M killing of tumor
cells, in which the reported data favor a major role for a
nitric oxide-independent cell killing mechanism because
nitric oxide release was only modestly suppressed.10
Both the latter study and the current work may have
methodological differences from experiments in which
nitric oxide-directed parasite killing was suppressed by
M binding of apoptotic cells.21 Nevertheless, a second
key conclusion of our work is that interaction with apo-
ptotic cells can suppress TNF-restricted M direction of
mesangial cell apoptosis.
We propose that further work should examine the like-
lihood that activated M deletion of resident cells at
inflamed sites may be subject to negative feedback con-
trol, in which ingestion of apoptotic cells down-regulates
M capacity to induce apoptosis in resident cells. This
new concept suggests additional deleterious conse-
quences should M clearance of apoptotic cells be de-
fective. Previously it has been proposed22,23 that re-
duced M capacity for clearance of leukocytes and other
cells undergoing apoptosis, as now demonstrated in
C1q/ knockout mice,24 threatens tissue injury be-
cause of the likelihood that cellular contents escaping
from noningested apoptotic cells undergoing secondary
necrosis will injure tissues directly and indirectly23 by
stimulating M release of injurious mediators. Our new
data indicate that failure to ingest apoptotic cells might
deprive activated M of a crucial off-signal resulting in
undesirably prolonged capacity to direct death of neigh-
boring cells by TNF-restricted mechanisms. Neverthe-
less, it is likely to be some time before this hypothesis can
be tested in vivo, because a growing body of evidence
argues that redundancy in clearance mechanisms may
require that a number are disabled before sustained
defects in clearance of apoptotic cells can be demon-
strated.25,26
Furthermore, future work will also need to address
whether M ingestion of apoptotic cells down-regu-
lates M membrane TNF- cell-surface expression, or
whether integrin co-factors, necessary for successful
transduction of the apoptotic signal, are down-regulat-
ed.5 Preliminary data suggest that membrane-bound
rather than soluble TNF- is responsible for M-di-
rected apoptosis of mesangial cells (J. Duffield and J.
Savill, unpublished data), as reported for M-directed
leukocyte apoptosis.5
To conclude, when macrophage release of nitric oxide
is minimal, as may be expected in human inflammation,
these data demonstrate a major role for TNF in activated
M killing of cytokine-primed mesangial cells by apopto-
sis. Furthermore, inhibition of the capacity to direct apo-
ptosis consequent on M binding/ingestion of apoptotic
cells reveals a new and potentially important negative
feedback control mechanism in remodeling of the in-
flamed site.
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